XML 40 R27.htm IDEA: XBRL DOCUMENT
v3.26.1

Balance Sheet Components (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Schedule of Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consists of the following (in thousands):
| As of
| March 31, 2026 |  | December 31, 2025
Accrued compensation | $ | 9,218 |  |  | $ | 32,179 |
Accrued clinical and other research & development costs | 21,475 |  |  | 22,283 |
Accrued manufacturing costs | 9,031 |  |  | 5,336 |
Operating lease liability, current | 9,769 |  |  | 9,463 |
Finance lease liability, current | 90 |  |  | 83 |
Deferred research and development funding liability, current | 15,116 |  |  | 21,101 |
Other accrued costs and current liabilities | 5,077 |  |  | 7,401 |
Total accrued expenses and other current liabilities | $ | 69,776 |  |  | $ | 97,846 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration